Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT06717711Phase 3Recruiting
Phase 3, randomised, open-label trial in erectile dysfunction (ED) (2 arms), sponsored by IRCCS Regina Elena National Cancer Institute. Primary endpoint: International Index of Erectile Function-5 at 12 months. Started Sep 2023; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT06717711.